experimental group:H008 tablets 2 tablets + lansoprazole enteric blank capsule 1 tablet, once a day
Sponsors
The First Affiliated Hospital of Sun Yat-Sen University
Conditions
Duodenal ulcerReflux esophagitis
Phase 3
A multi-center, randomized, double-blind, double-simulated, and positive-drug parallel-controlled Phase III clinical study to evaluate the effectiveness and safety of H008 tablets in patients with duodenal ulcer
RecruitingChiCTR2100043457
Start: 2020-08-21Updated: 2021-06-07
A multi-center, randomized, double-blind, double-simulated, and positive-drug parallel-controlled Phase III clinical study to evaluate the effectiveness and safety of H008 tablets in patients with reflux esophagitis
RecruitingChiCTR2100043456
Start: 2020-08-21Updated: 2021-06-07